Collegium Pharmaceutical (COLL) Earnings Date, Estimates & Call Transcripts $30.90 +0.18 (+0.59%) (As of 12/17/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get Collegium Pharmaceutical Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Collegium Pharmaceutical and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataCOLL Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.COLL Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Collegium Pharmaceutical Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241$1.28$1.28$1.28Q2 20242$1.39$1.40$1.40Q3 20242$1.29$1.41$1.35Q4 20242$1.58$1.77$1.68FY 20247$5.54$5.86$5.70Q2 20251$1.62$1.62$1.62Q3 20251$1.71$1.71$1.71 Collegium Pharmaceutical Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails8/8/2024Q2 2024$1.40$1.62+$0.22$2.34$143.94M$145.28M5/9/2024Q1 2024$1.36$1.32 -$0.04$1.93$147.04M$144.92M2/22/2024Q4 2023$1.20$1.45+$0.25$2.08$147.66M$149.75M11/7/2023Q3 2023$1.11$1.21+$0.10$1.89$139.55M$136.71M8/3/2023Q2 2023$1.11$1.13+$0.02$1.92$137.98M$135.55M5/4/2023Q1 2023$1.20$1.18 -$0.02$2.87$139.11M$144.77M Get the Latest News and Ratings for COLL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Collegium Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. 2/23/2023Q4 2022$0.88$0.98+$0.10$2.17$127.07M$129.62M Collegium Pharmaceutical Earnings - Frequently Asked Questions What guidance has Collegium Pharmaceutical issued on next quarter's earnings? Collegium Pharmaceutical issued an update on its FY 2024 earnings guidance on Thursday, November, 7th. The company issued revenue guidance of $620.0 million-$635.0 million, compared to the consensus revenue estimate of $625.4 million. How much revenue does Collegium Pharmaceutical generate each year? Collegium Pharmaceutical (NASDAQ:COLL) has a recorded annual revenue of $599.25 million. How much profit does Collegium Pharmaceutical generate each year? Collegium Pharmaceutical (NASDAQ:COLL) has a recorded net income of $48.15 million. COLL has generated $2.32 earnings per share over the last four quarters. What is Collegium Pharmaceutical's price-to-earnings ratio? Collegium Pharmaceutical (NASDAQ:COLL) has a trailing price-to-earnings ratio of 13.32 and a forward price-to-earnings ratio of 5.52. What is Collegium Pharmaceutical's EPS forecast for next year? Collegium Pharmaceutical's earnings are expected to grow from $5.60 per share to $6.07 per share in the next year, which is a 8.39% increase. More Earnings Resources from MarketBeat Related Companies OGN Earnings Date PTCT Earnings Date VRNA Earnings Date RYTM Earnings Date MLTX Earnings Date JANX Earnings Date EWTX Earnings Date XENE Earnings Date MRUS Earnings Date TWST Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles History Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of Earnings Vacuum up cash with these special trades? (Ad)Have you ever heard about a “volatility vacuum?” Most people haven’t. It all revolves around this formula right here. Now, the most important thing is that this equation — when applied to certain tickers at a certain time each month —- can trigger these “volatility vacuums.” And when that happens, anyone has the shot at sucking out payouts of $290, $350, even $1,350 in as little as 24 hours. (With just a $1k starting stake!) Granted, there were smaller wins and those that did not work out but best of all, we can know exactly when these opportunities will hit. I’ve used this info to create a Cash Calendar that lays out the precise dates of these payouts. And I’m sending it for FREE to anyone who joins me during my FREE training right here. This page (NASDAQ:COLL) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | Sponsored2025’s #1 Trump TradeAll the Energy You Need to Power Your Entire Life... Could Fit Inside This Single Soda Can. Three Companies...The Oxford Club | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored50-year Wall Street legend: “Sell this tech stock NOW”Something very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | SponsoredThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Collegium Pharmaceutical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Collegium Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
